THE IMPACT OF DIETARY PROTEIN OR AMINO ACID SUPPLEMENTATION ON MUSCLE MASS AND STRENGTH IN ELDERLY PEOPLE: INDIVIDUAL PARTICIPANT DATA AND META-ANALYSIS OF RCT’S

Objectives Increasing protein or amino acid intake has been promoted as a promising strategy to increase muscle mass and strength in elderly people, however, long-term intervention studies show inconsistent findings. Therefore, we aim to determine the impact of protein or amino acid supplementation compared to placebo on muscle mass and strength in older adults by combining the results from published trials in a metaanalysis and pooled individual participant data analysis. Design We searched Medline and Cochrane databases and performed a meta-analysis on eight available trials on the effect of protein or amino acid supplementation on muscle mass and strength in older adults. Furthermore, we pooled individual data of six of these randomized double-blind placebo-controlled trials. The main outcomes were change in lean body mass and change in muscle strength for both the meta-analysis and the pooled analysis. Results The meta-analysis of eight studies (n=557) showed no significant positive effects of protein or amino acid supplementation on lean body mass (mean difference: 0.014 kg: 95% CI -0.152; 0.18), leg press strength (mean difference: 2.26 kg: 95% CI -0.56; 5.08), leg extension strength (mean difference: 0.75 kg: 95% CI: -1.96, 3.47) or handgrip strength (mean difference: -0.002 kg: 95% CI -0.182; 0.179). Likewise, the pooled analysis showed no significant difference between protein and placebo treatment on lean body mass (n=412: p=0.78), leg press strength (n=121: p=0.50), leg extension strength (n=121: p=0.16) and handgrip strength (n=318: p=0.37). Conclusions There is currently no evidence to suggest that protein or amino acid supplementation without concomitant nutritional or exercise interventions increases muscle mass or strength in predominantly healthy elderly people

Metformin and the gastrointestinal tract

Metformin is an effective agent with a good safety profile that is widely used as a first-line treatment for type 2 diabetes, yet its mechanisms of action and variability in terms of efficacy and side effects remain poorly understood. Although the liver is recognised as a major site of metformin pharmacodynamics, recent evidence also implicates the gut as an important site of action. Metformin has a number of actions within the gut. It increases intestinal glucose uptake and lactate production, increases GLP-1 concentrations and the bile acid pool within the intestine, and alters the microbiome. A novel delayed-release preparation of metformin has recently been shown to improve glycaemic control to a similar extent to immediate-release metformin, but with less systemic exposure. We believe that metformin response and tolerance is intrinsically linked with the gut. This review examines the passage of metformin through the gut, and how this can affect the efficacy of metformin treatment in the individual, and contribute to the side effects associated with metformin intolerance

The Exxon and BP oil spills: a comparison of psychosocial impacts

We address the research question: ‘Did the 2010 BP Deepwater Horizon oil spill have similar psychosocial impacts as the 1989 Exxon Valdez oil spill?’ We answer this question by comparing survey results from a random sample of Cordova, Alaska, residents collected 18 months after the Exxon spill with a random sample of residents in the Alabama coastal counties of Baldwin and south Mobile 1 year after the BP disaster. Analysis revealed similarly high levels of psychological stress for survivors of both disasters. For residents of coastal Alabama, the strongest predictors of psychosocial stress were exposure to oil, ties to renewable resources, concerns about their economic future, worries about air quality, and safety issues regarding seafood harvests in oiled areas. Differences between south Mobile and Baldwin counties were related to the former community’s economic ties to renewable resources and Baldwin County’s dependence on tourism for economic sustainability

A site-selective amination catalyst discriminates between nearly identical C–H bonds of unsymmetrical disubstituted alkenes

C−H activation reactions enable chemists to unveil new retrosynthetic disconnections and streamline conventional synthetic approaches. A longstanding challenge in C−H activation is the inability to distinguish electronically and sterically similar C–H bonds. Although numerous synergistic combinations of transition-metal complexes and chelating directing groups have been utilized to distinguish C−H bonds, undirected regioselective C−H functionalization strategies remain elusive. Herein, we report a regioselective C−H activation/amination reaction of various unsymmetrical dialkyl-substituted alkenes. The regioselectivity of C−H activation is correlated to the electronic properties of allylic C−H bonds indicated by the corresponding 1JCH coupling constants. A linear relationship between the difference of 1JCH coupling constants of the two competing allylic C−H bonds (Δ 1JCH) and the C−H activation barriers (Δ ΔG ‡ ) has also been determined